Medical Cannabis Research

The Endocannabinoid System and Memory Disorders

THC and Memory: The most recent Journal of Cognitive Neuroscience reports on a study out of the University Medical Center in Utrecht, the Netherlands. Deficits in memory function are an incapacitating aspect of various psychiatric and neurological disorders. Animal studies have recently provided strong evidence for involvement of the endocannabinoid (eCB) system in memory function. The Abstract is posted here. read more…

Hazekamp & Grotenhermen: Review on clinical studies with cannabis and cannabinoids

To date, a large number of controlled clinical trials have been done evaluating the therapeutic applications of cannabis and cannabis-based preparations. This current review reports on the more recent clinical data available.

Published in Cannabinoids 2010;5(Special Issue): 1-21

Institute Biology Leiden, Leiden University, The Netherlands

Review of Recent Clinical Studies

Izzo: Non-Psychotropic Plant Cannabinoids

The plant Cannabis sativa produces over 421 chemical compounds, including about 80 terpeno-phenol compounds named phytocannabinoids that have not been detected in any other plant. Here, we provide an overview of the recent pharmacological advances, novel mechanisms of action, and potential therapeutic applications of such non-psychotropic plant-derived cannabinoids.

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

SCC Hears McAllister On Cannabis Cancer Research

SCC Hears McAllister On Cannabis Cancer ResearchSean McAllister, PhD, who has been studying the anti-cancer effects of cannabinoids in the laboratory (on a grant from NIH and with a license from the DEA). The occasion was the winter meeting of the Society of Cannabis Clinicians.”That’s a very good question,” McAllister would say…and provide the answer, and tie it back into his main thread. read more…